P16R (p.Pro16Arg) variant of EIF2AK4 (eIF-2-alpha kinase GCN2)

P16R (p.Pro16Arg) in EIF2AK4 (eIF-2-alpha kinase GCN2) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.22 / 1. The record also includes population frequency data and structural context.

P16R (p.Pro16Arg) variant details